NewsBenzingaAmneal Pharmaceuticals relève ses prévisions de BPA ajusté pour l’exercice 2026 de 0,96 $-1,06 $ à 1,04 $-1,08 $, contre 1,03 $ estimé ; relève ses prévisions de chiffre d’affaires pour l’exercice 2026 de 3,100 Md$-3,200 Md$ à 3,150 Md$-3,250 Md$... Amneal Pharmaceuticals relève ses prévisions de BPA ajusté pour l’exercice 2026 de 0,96 $-1,06 $ à 1,04 $-1,08 $, contre 1,03 $ estimé ; relève ses prévisions de chiffre d’affaires pour l’exercice 2026 de 3,100 Md$-3,200 Md$ à 3,150 Md$-3,250 Md$... Benzinga 2026.11.03 11:07 (GMT+0) Open on Benzinga Other news Paytaca: Backend Systems Attacked but User Funds and Private Keys Unaffected, Warns Against Interacting with Suspicious Orders ‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors Analysis: Bitcoin's 12% Weekly Drop and Break Below 200-Week Moving Average — All Three Similar Historical Cases Rose Three Months Later Can Colette Kress Fill Jensen Huang’s Shoes? Nvidia Posts $116 Billion Quarter, but Analyst Sees ‘Bigger Test’ Ahead Binance to Remove 5 Spot Trading Pairs Including GAS/TRY and HBAR/BNB on November 20 Micron Technology (MU) Stock Is Trending After Hours: Here's Why
Paytaca: Backend Systems Attacked but User Funds and Private Keys Unaffected, Warns Against Interacting with Suspicious Orders
‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors
Analysis: Bitcoin's 12% Weekly Drop and Break Below 200-Week Moving Average — All Three Similar Historical Cases Rose Three Months Later
Can Colette Kress Fill Jensen Huang’s Shoes? Nvidia Posts $116 Billion Quarter, but Analyst Sees ‘Bigger Test’ Ahead